Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report)’s stock price was down 2.9% on Thursday . The stock traded as low as $0.9668 and last traded at $0.9708. Approximately 581,510 shares traded hands during trading, an increase of 767% from the average daily volume of 67,097 shares. The stock had previously closed at $1.00.
Cardiol Therapeutics Stock Down 2.9%
The business has a fifty day simple moving average of $1.01 and a 200 day simple moving average of $1.05.
About Cardiol Therapeutics
Cardiol Therapeutics Inc is a clinical-stage biotechnology company focused on the development of novel immuno-lipid therapies for treating heart failure and inflammation-related cardiovascular diseases. The company’s proprietary platform is built on synthetic formulations of cardiolipin, a naturally occurring mitochondrial lipid known to play a key role in cellular energy production and inflammatory regulation. By harnessing the anti-inflammatory properties of cardiolipin derivatives, Cardiol aims to address unmet needs in acute and chronic cardiovascular conditions.
Cardiol’s lead product candidate, CT-1 Microspheres, is designed for intravenous administration to hospitalized patients with acute decompensated heart failure.
Read More
- Five stocks we like better than Cardiol Therapeutics
- The move Washington made in 1934
- What happened to Blockbuster is about to happen to computers
- The gold chart Wall Street is terrified of…
- What central banks are doing with gold right now
- Elon Musk’s $1 Quadrillion AI IPO
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
